Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

NACompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 30, 2018

Study Completion Date

August 30, 2021

Conditions

Hepatocellular Carcinoma(HCC)Cirrhotic Portal Hypertension

Interventions

PROCEDURE

Precise hepatectomy

OTHER

Combined intervention (chemoembolization/ablation)

transcatheter hepatic arterial chemoembolization and/or ablation

Trial Locations (1)

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT01642446 - Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension | Biotech Hunter | Biotech Hunter